Magnesium Valproate Extended-Release Tablets are mainly antiepileptic, belonging to the broad-spectrum antiepileptic drugs, which are therapeutic for many types of epilepsy, with anticonvulsant and antimanic effects. It is contraindicated for people suffering from leukopenia, severe liver disease and children under six years old. Magnesium Valproate Extended-Release Tablets can be used to treat many types of epilepsy, such as grand mal seizures, tonic clonic seizures, apoplectic seizures and atonic seizures. It can also be used in patients with focal epilepsy, such as simple and complex seizures. In addition, the drug acts as a mood stabilizer with antimanic effects and is mainly used in acute manic episodes and manic episodes in patients with bipolar disorder. Precautions should be followed when using the drug, which should be used with caution in cases of hepatic and renal insufficiency and thrombocytopenia. Liver function with white blood cell and platelet counts should be checked regularly during use of the drug. Serious adverse reactions such as impaired consciousness, abnormal liver function and pancreatitis should be discontinued. The occurrence of adverse reactions is mainly related to high blood concentration, so it is recommended to carry out blood concentration tests when using the drug. In addition, symptoms such as nausea, vomiting, diarrhea, drowsiness, tremor and abnormal excitement may occur after the use of the drug, and occasional allergy, thrombocytopenia or leukopenia, bleeding or toxic liver damage. The occurrence of these symptoms should be promptly treated in the hospital. Patients should follow the doctor’s instructions to use magnesium valproate extended-release tablets, do not adjust the dose or stop the drug, in order to avoid affecting the efficacy of treatment or adverse reactions.